Get the Daily Brief
Latest Biotech News
Breakthroughs in Spatial Proteomics and Cancer Research
Recent advancements in spatial proteomics include development of unbiased protein isolation via the Microscoop platform and the Deep Visual Proteomics (DVP) method enabling single-cell spatial...
New Genetic and Epigenetic Insights Into Neurological and Psychiatric Disorders
Groundbreaking studies continue to elucidate the molecular basis of neurological diseases. Research identifies autoimmune T cell responses targeting C9orf72 protein in ALS, repositioning the...
Advances in Cancer Immunotherapy and Targeted Treatment Strategies
Cancer therapeutics are advancing with novel immunotherapy and targeted agents. Ohio State researchers identify mechanisms of T cell exhaustion contributing to cancer immunotherapy failure....
Emerging Innovations in Diagnostic and Imaging Technologies
Significant strides are underway in diagnostic and imaging modalities. AI-powered models predict prostate cancer Gleason scores using MRI and enhance extranodal extension detection in HPV-positive...
Genmab Acquires Merus in $8 Billion Bispecific Antibody Deal
Genmab has agreed to acquire clinical-stage biotechnology company Merus for approximately $8 billion in an all-cash transaction aimed at expanding its late-stage oncology pipeline. The acquisition...
Pfizer and Trump Strike Drug Pricing Deal with Direct-to-Consumer Platform
Pfizer has inked a groundbreaking pricing agreement with the White House to offer certain drugs at most-favored-nation pricing, aligning U.S. medication costs with lower prices in other developed...
UK Gene Editing Startup Forge Genetics Raises £2.7 Million Seed Funding
Forge Genetics, a UK-based gene editing startup spun out from the University of Nottingham, has raised £2 million (approximately $2.7 million) in seed funding led by Mercia Ventures and supported...
AI Model Developed to Optimize Protein Drug Production in CHO Cells
Researchers from New York, including Susan Sharfstein, PhD, have partnered with DeepSeq.AI to develop an artificial intelligence model predicting the manufacturability of protein-based drugs in...
Breakthrough in Amyotrophic Lateral Sclerosis Suggests Autoimmune Disease Component
New studies by researchers at La Jolla Institute for Immunology and Columbia University Irving Medical Center reveal that amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder,...
Machine Learning Radiomics Predicts Pancreatic Cancer Perineural Invasion
A study published in BMC Cancer demonstrates that radiomic analysis of contrast-enhanced computed tomography (CECT) images combined with machine learning algorithms can predict perineural invasion...
Symbiosis Pharmaceutical Expands Automated Sterile Manufacturing Capacity
Symbiosis Pharmaceutical Services has completed qualification of its new automated FPD 50 Flexicon fill/finish line at a commercial production facility in Stirling, Scotland. The line features a...
Carnegie Mellon Secures $26.7M ARPA-H Grant for At-Home Cancer Screening Technology
Carnegie Mellon University leads a multi-institutional collaboration awarded $26.7 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop next-generation at-home cancer...
Innovative Biochar Treatment Alleviates Soil Heavy Metal Toxicity in Agriculture
Researchers in China have developed a phosphorus-modified biochar derived from apple tree branches that effectively reduces heavy metal contamination in soils and enhances crop safety. This novel...
Genmab’s $8 Billion Merus Acquisition Expands Bispecific Antibody Pipeline
Genmab has agreed to acquire Merus for approximately $8 billion, securing full ownership of Merus’ promising bispecific antibody therapeutic petosemtamab, targeting head and neck cancer. This...
New Biotech Aerska Secures $21 Million to Deliver RNAi Drugs to Brain
Dublin-based startup Aerska launched with a $21 million seed funding round to develop technology that transports RNA interference (RNAi) therapeutics across the blood-brain barrier. This addresses...
Direct-to-Patient Pharma Platforms Expand Access Amid Pricing Initiatives
Pharmaceutical companies including AstraZeneca and Boehringer Ingelheim, along with new entrants, have launched direct-to-patient prescription programs in the U.S. to improve medication access and...
NRG Oncology Trials Showcase Advances in Cancer Treatment Effectiveness
Recent NRG Oncology studies reveal significant improvements in cancer treatment outcomes across multiple cancers. A Phase II trial combining proton therapy with immunotherapy showed promising...
Ansa Biotechnologies Closes $54.4 Million Series B to Scale DNA Manufacturing
California-based Ansa Biotechnologies secured $54.4 million in Series B funding led by Cerberus Ventures to expand U.S.-based enzymatic DNA synthesis capacity. The company’s innovative DNA...
Advances in AI and Multi-Omics Enable Precision Oncology and Disease Detection
Innovations leveraging artificial intelligence and multi-omics data are revolutionizing precision diagnostics and oncology. Precision oncology firm Predicta Biosciences raised $23.4 million to...
FDA and Drug Pricing Developments Impact Biotech Market and Regulatory Landscape
Significant regulatory and pricing shifts are affecting the biotech and pharmaceutical industries. The FDA faces challenges due to impending government shutdowns, resulting in staffing reductions...